tiprankstipranks
Trending News
More News >
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315)
:2315
Hong Kong Market

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (2315) Cash flow

Compare
1 Followers

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H Cash Flow

HK:2315's free cash flow for Q2 2024 was ¥3.59M. For the 2024 fiscal year, HK:2315's free cash flow was decreased by ¥377.38M and operating cash flow was ¥14.80M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
¥ 211.25M¥ -76.65M¥ -303.27M¥ -365.78M¥ -225.31M
Investing Cash Flow
¥ -137.12M¥ -100.28M¥ -153.74M¥ -84.13M¥ -188.18M
Financing Cash Flow
¥ -92.03M¥ -37.82M¥ 587.20M¥ 219.44M¥ 868.44M
End Cash Position
¥ 384.46M¥ 399.61M¥ 610.88M¥ 466.44M¥ 697.29M
Free Cash Flow
¥ 174.12M¥ -203.26M¥ -543.94M¥ -564.45M¥ -531.73M
Currency in CNY

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis